For those trying to value up AVH, you might also consider putting your money into a high interest bearing bank account. Safe, with a guaranteed income. Or, into a blue chip that pays good dividends.
In a year, possibly two, when the anticipated FDA approval is closer to actually happening, you might want a fresh and serious look at moving into AVH.
But who knows, a curve ball may be thrown at the 11th hour, and FDA approval is not granted. Anyone who just assumes approval is a fait accompli is just plain arrogant. EVERYTHING is riding on successful FDA approval. Everything.
We read about SP valuations in the dollars here. Considering that ReCell is already available in most parts of the world right now, this highlights the absolute importance of FDA approval in the USA. Otherwise AVH would be trading significantly higher than low 20 cents. Which raises the question: why isn't it?
There has been impressive short term gains to be had in recent months, look at any graph, but expect AVH to drift sideways for quite some time moving forward.
Read back through the AVH posts here, and even the loudest AVH fans concede that the only thing that matters is FDA approval. I can post links to these comments below, if that is helpful?
AVH Price at posting:
22.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)